The journey of iSMART began during one of the most challenging times in modern history, the COVID-19 pandemic. With the world struggling with the urgent need for rapid and accurate diagnostic solutions, the idea for iSMART was born out of innovation, necessity, and inspiration from Artificial Intelligence.
AI technologies will enhance medical care by providing accurate diagnostics, personalised treatment plans, and real-time health monitoring.
AI in health will streamline workflows, empower early interventions, and improve patient outcomes worldwide.
iSMART technology revolutionises patient care with its innovative approach, reducing healthcare burdens, empowering clinicians, and improving patient access to timely and effective treatments.
Revolutionising medicine by enabling rapid, accurate diagnostics, reducing human errors, and personalised treatments, transforming patient care.
Enhance efficiency, reduces healthcare burdens, and empowers early disease detection and alert about emerging health threats.
Secure data exchange in AI-driven medicine ensures patient confidentiality and seamless collaboration, safeguarding sensitive information while enabling innovative healthcare solutions.
AI is pivotal in combating future health threats by enabling early interventions and accelerating the development of life-saving treatments.
During the early days of the pandemic, our scientists discovered that certain trained dogs could detect diseases, including COVID-19, with extraordinary accuracy using their sense of smell. This remarkable ability sparked the idea of developing organic sensors that could replicate the precision of a dog’s nose in detecting viral body odours.
The first-generation iSMARTⓇ system focused on creating organic sensors capable to detect COVID-19 carriers by analysing body odours associated with the virus and the resulting changes in volatile organic compounds (VOCs). These sensors achieved near-perfect accuracy in laboratory tests, marking a breakthrough in diagnostic technology.
Building on the success of the initial sensors, the second-generation iSMARTⓇ incorporated advanced artificial intelligence (AI) algorithms. These algorithms enhanced the system’s ability to analyse complex patterns in VOC data, making diagnostics faster, more reliable, and scalable for widespread use. This phase also saw the integration of real-time data analysis capabilities. Governments and health organisations could use iSMARTⓇ terminals to monitor COVID-19 hotspots dynamically, enabling swift intervention and resource allocation. Italy was one of the first countries to deploy these AI-powered terminals, which proved instrumental in saving lives and mitigating the pandemic’s impact.
The first-generation iSMARTⓇ system focused on creating organic sensors capable to detect COVID-19 carriers by analysing body odours associated with the virus and the resulting changes in volatile organic compounds (VOCs). These sensors achieved near-perfect accuracy in laboratory tests, marking a breakthrough in diagnostic technology.
The early success of iSMART highlighted AI’s potential to revolutionise diagnostics beyond COVID-19.
We combined all our expertise to create a healthcare solution like no other.
